Literature DB >> 11889158

Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus.

Jerry R Greenfield1, Katherine Samaras, Donald J Chisholm.   

Abstract

The increased cardiovascular risk in type 1 diabetes may be related, at least in part, to insulin resistance. The aim of this study was to assess the relationships between insulin sensitivity, abdominal fat, androgens, lipids, and blood pressure in 10 premenopausal women with type 1 diabetes (mean +/- SD, hemoglobin A1c 8.1 +/- 1.0%) and 10 nondiabetic body mass index-matched controls. Insulin sensitivity (glucose infusion rate during euglycemic-hyperinsulinemic clamp) was significantly less in the type 1 diabetes group than in controls (49.3 +/- 14.8 vs. 73.2 +/- 21.6 micromol/min x kg fat free mass, respectively, P = 0.01). The two groups were similar with respect to lipids, androgens, energy expenditure, physical activity, blood pressure, and abdominal adiposity (intra-abdominal fat by four-slice computed tomography and central abdominal fat by dual-energy x-ray absorptiometry). There were no relationships between glucose infusion rate, abdominal adiposity, and androgen levels in subjects with type 1 diabetes, in contrast to controls. Our results demonstrate greater insulin resistance in a group of premenopausal women with type 1 diabetes compared with nondiabetic controls, unrelated to abdominal adiposity, lipids, or androgens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889158     DOI: 10.1210/jcem.87.3.8324

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Metabolic control and body mass index in patients with type 1 diabetes on different insulin regimens.

Authors:  Indira Kulenović; Senija Rasić; Mirko Grujić
Journal:  Bosn J Basic Med Sci       Date:  2004-02       Impact factor: 3.363

2.  Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men.

Authors:  Katarzyna Dunajska; Andrzej Milewicz; Diana Jedrzejuk; Jadwiga Szymczak; Wiktor Kuliczkowski; Piotr Salomon; Dariusz Bialy; Karol Poczatek; Przemysław Nowicki
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

3.  Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance.

Authors:  David M Maahs; John E Hokanson; Hong Wang; Gregory L Kinney; Janet K Snell-Bergeon; Ashley East; Bryan C Bergman; Irene E Schauer; Marian Rewers; Robert H Eckel
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

4.  Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.

Authors:  Kristen J Nadeau; Judith G Regensteiner; Timothy A Bauer; Mark S Brown; Jennifer L Dorosz; Amber Hull; Phil Zeitler; Boris Draznin; Jane E B Reusch
Journal:  J Clin Endocrinol Metab       Date:  2009-11-13       Impact factor: 5.958

Review 5.  Protective effects of physical activity against health risks associated with type 1 diabetes: "Health benefits outweigh the risks".

Authors:  Addisu Dabi Wake
Journal:  World J Diabetes       Date:  2022-03-15

6.  Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?

Authors:  Jennifer R Snaith; Jerry R Greenfield
Journal:  Med J Aust       Date:  2022-06-30       Impact factor: 12.776

7.  Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

Authors:  Krishnarajah Nirantharakumar; Nuredin Mohammed; Konstantinos A Toulis; G Neil Thomas; Parth Narendran
Journal:  Diabetologia       Date:  2018-02-24       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.